Difference between revisions of "Stephen Moses"
Jump to navigation
Jump to search
m |
m (adjusted REFjournal) |
||
| Line 20: | Line 20: | ||
'''Stephen Moses''', Professor, Departments of Medical Microbiology, Community Health Sciences and Medicine. Stephen Moses has been a circumcision proponent since at least 1994.<ref name="Moses1994">{{REFjournal | '''Stephen Moses''', Professor, Departments of Medical Microbiology, Community Health Sciences and Medicine. Stephen Moses has been a circumcision proponent since at least 1994.<ref name="Moses1994">{{REFjournal | ||
|last=Moses | |last=Moses | ||
| − | | | + | |init=S |
| − | | | + | |author-link=Stephen Moses |
| − | | | + | |last2=Plummer |
| − | | | + | |init2=FA |
| − | | | + | |last3=Bradley |
| − | | | + | |init3=JE |
| − | | | + | |last4=Ndinya-Achola |
| − | | | + | |init4=JO |
| − | | | + | |last5=Nagelkerke |
| − | | | + | |init5=NJ |
| − | | | + | |last6=Ronald |
| + | |init6=AR | ||
|title=The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data | |title=The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data | ||
|journal=Sex Transm Dis | |journal=Sex Transm Dis | ||
| Line 38: | Line 39: | ||
}}</ref> Moses (along with [[Robert C. Bailey]]) was responsible for one of the three major African circumcision trials (funded by NIAID and the Canadian Institutes of Health Research)<ref>{{REFjournal | }}</ref> Moses (along with [[Robert C. Bailey]]) was responsible for one of the three major African circumcision trials (funded by NIAID and the Canadian Institutes of Health Research)<ref>{{REFjournal | ||
|last=Krieger | |last=Krieger | ||
| − | | | + | |init=JN |
|last2=Bailey | |last2=Bailey | ||
| − | | | + | |init2=RC |
|last3=Opeya | |last3=Opeya | ||
| − | | | + | |init3=J |
|etal=yes | |etal=yes | ||
|date=2005-11 | |date=2005-11 | ||
| Line 65: | Line 66: | ||
== Interests == | == Interests == | ||
According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/HIV transmission.<ref name='moses-bio'>{{REFweb | According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/HIV transmission.<ref name='moses-bio'>{{REFweb | ||
| − | |last= | + | |last=Moses |
|first=Stephen | |first=Stephen | ||
| − | |title= | + | |title=Dr. Stephen Moses |
|url=http://umanitoba.ca/faculties/medicine/units/medical_microbiology/faculty/StephenMoses.html | |url=http://umanitoba.ca/faculties/medicine/units/medical_microbiology/faculty/StephenMoses.html | ||
|publisher=University of Manitoba | |publisher=University of Manitoba | ||
| Line 89: | Line 90: | ||
|last=Boyle | |last=Boyle | ||
|first=Gregory J. | |first=Gregory J. | ||
| + | |init=GJ | ||
|author-link= | |author-link= | ||
|last2=Hill | |last2=Hill | ||
|first2=George | |first2=George | ||
| + | |init2=G | ||
|author2-link=George Hill | |author2-link=George Hill | ||
|title=Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns | |title=Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns | ||
| Line 107: | Line 110: | ||
}}</ref> Garenne & Matthews (2019) report that circumcised men have as much HIV infection as intact men.<ref>{{REFjournal | }}</ref> Garenne & Matthews (2019) report that circumcised men have as much HIV infection as intact men.<ref>{{REFjournal | ||
|last=Garenne | |last=Garenne | ||
| − | | | + | |init=M |
|author-link= | |author-link= | ||
|last2=Matthews | |last2=Matthews | ||
| − | | | + | |init2=A |
|author2-link= | |author2-link= | ||
|etal=no | |etal=no | ||
| Line 140: | Line 143: | ||
* Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.<ref>{{REFjournal | * Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.<ref>{{REFjournal | ||
|last=Smith | |last=Smith | ||
| − | | | + | |init=JS |
|last2=Backes | |last2=Backes | ||
| − | | | + | |init2=DM |
|last3=Hudgens | |last3=Hudgens | ||
| − | | | + | |init3=MG |
|etal=yes | |etal=yes | ||
|date=2010-01 | |date=2010-01 | ||
| Line 160: | Line 163: | ||
* Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.<ref>{{REFjournal | * Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.<ref>{{REFjournal | ||
|last=Moses | |last=Moses | ||
| − | | | + | |init=S |
| + | |author-link=Stephen Moses | ||
|date=2009-10 | |date=2009-10 | ||
|title=Male circumcision: a new approach to reducing HIV transmission | |title=Male circumcision: a new approach to reducing HIV transmission | ||
| Line 175: | Line 179: | ||
* Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>{{REFjournal | * Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.<ref>{{REFjournal | ||
|last=Mehta | |last=Mehta | ||
| − | | | + | |init=SD |
|last2=Gray | |last2=Gray | ||
| − | | | + | |init2=RH |
|last3=Auvert | |last3=Auvert | ||
| − | | | + | |init3=B |
|etal=yes | |etal=yes | ||
|date=2007-07 | |date=2007-07 | ||
| Line 196: | Line 200: | ||
* Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.<ref>{{REFjournal | * Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.<ref>{{REFjournal | ||
|last=Bailey | |last=Bailey | ||
| − | | | + | |init=RC |
|last2=Moses | |last2=Moses | ||
| − | | | + | |init2=S |
| + | |author2-link=Stephen Moses | ||
|last3=Parker | |last3=Parker | ||
| − | | | + | |init3=CB |
|etal=yes | |etal=yes | ||
|date=2007-02 | |date=2007-02 | ||
| Line 216: | Line 221: | ||
* Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.<ref>{{REFjournal | * Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.<ref>{{REFjournal | ||
|last=Nagelkerke | |last=Nagelkerke | ||
| − | | | + | |init=NJ |
|last2=Moses | |last2=Moses | ||
| − | | | + | |init2=S |
| + | |author2-link=Stephen Moses | ||
|last3=de Vlas | |last3=de Vlas | ||
| − | | | + | |init3=SJ |
|last4=Bailey | |last4=Bailey | ||
| − | | | + | |init4=RC |
|date=2007 | |date=2007 | ||
|title=Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa | |title=Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa | ||
| Line 237: | Line 243: | ||
* Adult male circumcision outcomes: experience in a developing country setting.<ref>{{REFjournal | * Adult male circumcision outcomes: experience in a developing country setting.<ref>{{REFjournal | ||
|last=Krieger | |last=Krieger | ||
| − | | | + | |init=JN |
|last2=Bailey | |last2=Bailey | ||
| − | | | + | |init2=RC |
|last3=Opeya | |last3=Opeya | ||
| − | | | + | |init3=JC |
|etal=yes | |etal=yes | ||
|date=2007 | |date=2007 | ||
Revision as of 22:46, 29 December 2020
|
| Stephen Moses |
| Associates With: |
| Gilgal Society Circlist |
| Colleagues & Benefactors: |
| Daniel T. Halperin Edgar J. Schoen Robert C. Bailey Bertran Auvert Maria J. Wawer Brian J. Morris |
Stephen Moses, Professor, Departments of Medical Microbiology, Community Health Sciences and Medicine. Stephen Moses has been a circumcision proponent since at least 1994.[1] Moses (along with Robert C. Bailey) was responsible for one of the three major African circumcision trials (funded by NIAID and the Canadian Institutes of Health Research)[2] which are being used by the World Health Organization (under the guide of UNAIDS) to endorse circumcision as an HIV prevention method.[3]
Interests
According to Stephen's bio, his interest is in biological and behavioural risk factors for STI/HIV transmission.[4] Moses has been an advocate of circumcision since at least 1994.[1]
RCT in Kenya
Three trials were funded by the American National Institutes of Health.[5]Of the three RCTs being used by the WHO to endorse circumcision as HIV prevention, Stephen Moses and Robert C. Bailey headed the RCT that was carried out in Kenya.[6] Moses obviously brought his pre-existing bias in favor of male circumcision into the trial, so he did not start from a neutral position.
Moses' research on circumcision protection from HIV infection is now completely discredited. Boyle & Hill (2011) reviewed the three randomized controlled trials (RCTs) and found disabling methodological and statistical errors in all three. Although a 60 percent relative reduction in HIV was claimed, the absolute reduction was a statistically insignificant 1.3 percent.[7] Garenne & Matthews (2019) report that circumcised men have as much HIV infection as intact men.[8]
Active projects
- A randomized, controlled trial of male circumcision to reduce HIV incidence in Kisumu, Kenya.[4]
National Institutes of Health. - Scaling up HIV prevention in Karnataka and southern Maharashtra, Phase II.[4]
Bill & Melinda Gates Foundation. - Monitoring and evaluation of the Avahan project in India.[4]
Bill & Melinda Gates Foundation. - Technical assistance to improve maternal, neonatal & child health through National Rural Health Mission, India.[4]
Bill & Melinda Gates Foundation. - Mapping key populations for HIV prevention in Sri Lanka.[4]
World Bank.
Recent publications
- Prevalence and risk factors for human papillomavirus infection by penile site in uncircumcised Kenyan men.[9]
Smith JS, Hudgens MG, Bailey RC, Agot K, Ndinya-Achola JO, Moses S, et al. Int J Cancer 2010; 126: 572-7. - Top Achievements in Health Research: Male circumcision: a new approach to reducing HIV transmission.[10]
Moses S. CIHR/CMAJ 2009; 181: E134-5. - Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials.[11]
Mehta SD, Gray RH, Auvert B, Moses S , Kigozi G, Taljaard D, Puren A, Agot K, Serwadda D, Parker CB, Wawer MJ, Bailey RC. AIDS 2009; 23: 1557-64. - Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial.[12]
Bailey RC, Moses S , Parker CB, Agot K, Maclean I, Krieger JN, et al. Lancet 2007; 369: 643-56. - Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa.[13]
Nagelkerke NJD, Moses S, de Vlas S, Bailey RC. BMC Infect Dis 2007; 7: 16. - Adult male circumcision outcomes: experience in a developing country setting.[14]
Krieger J, Bailey RC, Agot K, Parker C, Ndinya-Achola JO, Moses S, et al. Urol Int 2007; 78: 235-40.
See also
References
- ↑ a b
Moses S, Plummer FA, Bradley JE, Ndinya-Achola JO, Nagelkerke NJ, Ronald AR. The association between lack of male circumcision and risk for HIV infection: a review of the epidemiological data. Sex Transm Dis. 1994; 21: 201-210.
- ↑ Krieger JN, Bailey RC, Opeya J, et al. Adult male circumcision: results of a standardized procedure in Kisumu District, Kenya. BJU Int.. November 2005; 96(7): 1109–13. PMID. DOI.
- ↑
World Health Organization (27 March 2007). WHO and UNAIDS announce recommendations from expert consultation on male circumcision for HIV prevention
. Retrieved 23 February 2011. - ↑ a b c d e f Moses, Stephen.
Dr. Stephen Moses
, University of Manitoba. Retrieved 23 February 2011. - ↑ (2016).
HIV/AIDS
, Doctors Opposing Circumcision. Retrieved 23 March 2020.
Quote:...funding from the United States National Institutes of Health to conduct randomized controlled trials (RCTs) in Africa.
- ↑ Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007;369:643-56. Abstract
- ↑ Boyle GJ, Hill G. Sub-Saharan African randomised clinical trials into male circumcision and HIV transmission: Methodological, ethical and legal concerns. J Law Med. December 2011; 19(2): 316-334. PMID. Retrieved 23 March 2020.
- ↑ Garenne M, Matthews A. Voluntary medical male circumcision and HIV in Zambia: expectations and observations. J Biosoc Science. 1 October 2019; 14: 1-13. PMID. DOI. Retrieved 25 March 2020.
- ↑ Smith JS, Backes DM, Hudgens MG, et al. Prevalence and risk factors of human papillomavirus infection by penile site in uncircumcised Kenyan men. Int. J. Cancer. January 2010; 126(2): 572–7. PMID. PMC. DOI.
- ↑ Moses S. Male circumcision: a new approach to reducing HIV transmission. CMAJ. October 2009; 181(8): E134–5. PMID. PMC. DOI.
- ↑ Mehta SD, Gray RH, Auvert B, et al. Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS. July 2007; 23(12): 1557–64. PMID. PMC. DOI.
- ↑ Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet. February 2007; 369(9562): 643–56. PMID. DOI.
- ↑ Nagelkerke NJ, Moses S, de Vlas SJ, Bailey RC. Modelling the public health impact of male circumcision for HIV prevention in high prevalence areas in Africa. BMC Infect. Dis.. 2007; 7: 16. PMID. PMC. DOI.
- ↑ Krieger JN, Bailey RC, Opeya JC, et al. Adult male circumcision outcomes: experience in a developing country setting. Urol. Int.. 2007; 78(3): 235–40. PMID. DOI.
